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Abstract: White matter lesions have detrimental effects upon older adults, while serum 
calcium levels have been associated with elevated vascular risk and may be associated with 
these lesions. Depression, a serious mental disorder characterized by disturbances in 
calcium metabolism, may be an important contributor to any calcium-lesion relationship. 
This cross-sectional pilot study examined the association between serum ionized calcium 
(the physiologically active form of calcium) and white matter lesion volumes in a sample 
of depressed and non-depressed older adults (N = 42; 60 years and older). Serum ionized 
calcium was determined using an ion-selective electrode technique, while lesion volumes 
were estimated from magnetic resonance imaging using an automated expectation-maximization 
segmentation. A linear regression model, controlling for age and group (depression vs. 
comparison), showed a trend for a positive relationship between serum ionized calcium and 
white matter lesion volume (β = 4.34, SE = 2.27, t = 1.91, p = 0.063). Subsample analyses 
with depressed participants showed a significant positive relationship between higher ionic 
calcium and greater lesion volume (β = 6.41, SE = 2.53, t = 2.53, p = 0.018), but no 
association was found for non-depressed participants. Sex-specific subsample analyses 
showed a significant positive relationship between higher calcium and greater lesion 
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volume in men only (β = 7.49, SE = 3.42, t = 2.19, p = 0.041). These preliminary results 
indicate that serum ionized calcium may be associated with white matter lesions in older 
adults, particularly among men and individuals with depression. Larger studies are needed 
to confirm these findings. 
Keywords: calcium; serum ionic calcium; white matter lesion; white matter hyperintensity; 
brain; older adult; depression 
 
1. Introduction 
Brain white matter lesions (WMLs), also known as white matter hyperintensities or leukoaraiosis, 
are areas of damage viewed on magnetic resonance imaging (MRI) (Figure 1). WMLs, which are 
primarily ischemic in origin [1], are common in older adults and promote the development and 
progression of late-life depression [2,3], a debilitating condition with a prevalence of between 2.7% 
and 10.1% in elders [4,5]. WMLs also increase risk of other detrimental health conditions, including 
cognitive decline, dementia, stroke, physical disability, hip fracture and death [6–13]. Aging of the 
population, combined with the obesity epidemic and related hypertension, may significantly increase 
prevalence of WMLs and their outcomes. 
Figure 1. White matter lesions (WMLs) shown on magnetic resonance imaging:  
Fluid-attenuated inversion recovery image (left), tissue classification image (right; lesions 
in red). Images are for illustrative purposes only. The images were derived from a 3 Tesla 
MRI acquisition and processing for a participant in the parent study (NCODE), although 
this individual was not a participant of the present serum calcium study. 
 
Serum calcium is one unexplored factor that may influence WMLs, especially given that WMLs 
result primarily from ischemic damage [1]. Elevated serum calcium levels, even those within the 
normal range, have been linked to greater risk of death, myocardial infarction, other cardiovascular 
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events, and stroke [14–17]. In addition, greater baseline serum calcium has been associated with 
diminished performance as well as faster decline in cognitive testing in older adults [18]. One 
mechanism by which serum calcium may promote WMLs is arterial calcification. Elevated serum 
calcium has been associated with aortic and carotid calcification and plaques [19–21], while arterial 
calcification has been cross-sectionally and longitudinally associated with greater WMLs [22–24]. 
Determining the role of serum calcium for WMLs is critical because of the damaging effects of these 
lesions and the potentially modifiable nature of serum calcium. This question is especially important 
for women’s health because women are at greater risk of depression and dementia, conditions  
that are partially promoted by WMLs [2,8]. In addition, women are more likely to use calcium 
supplements, products which may cause greater perturbations in serum calcium than do food forms of 
calcium [25,26]. 
Several conditions have been linked to disturbances in calcium metabolism, including  
hypertension [27], renal disease [28], and, of particular relevance for the present study, depression. A 
serious and common mental illness, depression is a leading cause of disability worldwide [29]. 
Depression has been characterized as a disorder of calcium metabolism as evidenced by elevations in 
serum [30] and cerebrospinal [31] calcium levels, and alterations in intracellular calcium [32]. In 
addition, dietary calcium has been shown to promote learned helplessness [33], an animal model of 
depression, while calcium channel blockers alleviate learned helplessness [34] and may also augment 
antidepressant therapy in humans [35]. This calcium dysregulation may be an unexplored explanatory 
factor for the elevation of WMLs observed with late-life depression. 
The aim of this pilot study of older adults was to evaluate the relationship between WMLs and 
serum ionized calcium (serum Cai). We hypothesized that higher levels of serum Cai would be 
positively associated with greater WML volumes. A secondary aim was to explore the role of calcium 
in depressed participants, given that depressed individuals exhibit calcium dysregulation and have 
higher WML volumes. In addition, we sought to explore the potential for sex differences in any 
identified calcium-WML relationship. 
2. Methods 
This pilot study was conducted as part of a larger longitudinal clinical examination of depressed and 
non-depressed older adults (NeuroCognitive Outcomes of Depression in the Elderly [NCODE]), which 
began in 1994 and had ongoing enrollment until 2011 [36]. Serum samples, for calcium and other 
measures, were collected between 6/1/2011 and 6/30/2012 from newly-enrolled participants as well as 
previously-enrolled participants when they came in for an annual study visit. MRI brain scans were 
acquired on all study participants, beginning at their baseline visit. For this project only participants 
with 3 Tesla (3T) MRIs (acquired 2003 and later) were included; the MRI closest in time to lab draw 
was used for WML quantification. 
2.1. Sample 
All participants who had both serum Cai and WML data (from 3T MRI) were included in the 
current study. This sample included patients who met DSM-IV diagnostic criteria for major depressive 
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disorder at study baseline, and never-depressed comparison participants recruited from the community. 
Participants were aged 60 years or older, and could speak and write English.  
Exclusion criteria included a concurrent diagnosis of a psychiatric or neurological illness, and 
significant cognitive impairment (as indicated by a Mini-Mental State Examination score of less than 
24 out of 30) [37]. Comparison participants (controls) were required to have no evidence of a current 
or lifetime depression diagnosis. 
After complete description of the study to the participants, written informed consent was obtained. 
A separate consent form was completed by previously-enrolled participants for the serum Cai and 
other assessments. New participants completed one consent form that included lab assessments in 
addition to other study procedures. This research protocol has been reviewed and approved by the 
Duke University Institutional Review Board (IRB), and was in compliance with Health Insurance 
Portability and Accountability Act (HIPAA) guidelines. 
2.2. Treatment 
Depression patients received individualized treatment from a psychiatrist, who followed them 
throughout the study. Most depressed participants received antidepressant medication. 
2.3. Measures 
2.3.1. Laboratory Assessment 
Lab measures included serum Cai, parathyroid hormone (PTH), 25-hydroxy-vitamin D, and 
phosphorus. The majority of participants were fasting for the blood draw (N = 37), although this was 
not a requirement for any lab measure except phosphorus. After collection and centrifuge, if indicated, 
samples were taken on the same day via LabCorp courier to a LabCorp facility (Burlington, NC) for 
analysis. Serum Cai utilized a separate gel-barrier tube (kept at room temperature, and labeled “Do Not 
Open”), and assessment was conducted with an ion-selective electrode methodology (reference 
interval: 4.5–5.6 mg/dL). Plasma PTH utilized an EDTA tube (kept refrigerated), and assessment was 
conducted by electrochemiluminescence immunoassay (reference interval: 15–65 pg/mL). Vitamin D 
measurement utilized a gel-barrier tube (kept refrigerated) and immunochemiluminometric assay 
(reference interval: 32–100 ng/mL). Serum phosphorus utilized a gel-barrier tube (kept at room 
temperature), and was calculated by calorimetric procedure (reference interval: 2.5–4.5 mg/dL). 
2.3.2. White Matter Lesion (WML) Volumes 
Cranial MRI was performed using the 8-channel parallel imaging head coil on a 3T whole-body 
MRI system (Trio, Siemens Medical Systems, Malvern, PA, USA). Proton density (PD), T1-weighted,  
T2-weighted, and fluid-attenuated inversion recovery (FLAIR) images were acquired. Parallel imaging 
was employed with an acceleration factor of 2. The pulse sequence parameters have been described 
previously [38]. The MR images were processed for WML volumes using an automated method in the 
Neuropsychiatric Imaging Research Laboratory (NIRL). This automated 4-channel lesion segmentation, 
which takes advantage of FLAIR images for WML detection, was performed, as previously developed 
by our group [38]. The method was optimized for vascular WML assessment in elderly subjects. 
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WMLs are detected as “outliers” to the normal tissue distributions. The method is capable of 
distinguishing and classifying WMLs and other brain tissues simultaneously. 
2.3.3. Covariates 
Covariates presented include basic demographics (age, sex, race), years of education, group 
(depression vs. comparison), and hypertension. Age was that at time of MRI scan. Hypertension (“high 
blood pressure”) was included with self-reported physical health items from the National Institute of 
Mental Health (NIMH) Diagnostic Interview Schedule [39] portion of the Duke Depression Evaluation 
Schedule (DDES), which was administered annually. MMSE, a global measure of cognition, was 
assessed every 6 to 12 months. For hypertension and MMSE, the data obtained from the closest 
assessment (to lab collection date) was used. 
2.4. Statistical Analyses 
All statistical analyses were done using JMP software, version 8.0 (SAS Institute, Inc.; Cary, NC, 
USA). Significance was defined at p < 0.05 level, although trends (0.05 ≥ p < 0.10) were considered 
given the small sample size. Given small numbers of minority participants, race was dichotomized as 
White vs. non-White. 
For bivariate analysis, t-tests were performed on continuous level variables and Chi-Square tests 
were performed on categorical variables testing for differences between depressed and non-depressed 
comparison participants. A simple regression model was fit to examine relationship between Cai and 
WML volume. A multivariable model was fit to examine this relationship after inclusion of covariates. 
Given the limited sample size, covariates were restricted to group (depressed vs. non-depressed) and 
age only. Hypertension was considered as a covariate, but was not included because of missing values 
(data only available for N = 35 (of N = 42)). Secondary analyses included an examination of separate 
regression models for each participant group (depression and comparison), as well as men vs. women. 
3. Results 
3.1. Participant Characteristics 
This pilot sample of older adults included a total of 42 participants (N = 29 depressed participants, 
N = 13 non-depressed comparison participants). See Table 1 for participant characteristics, including 
comparison of depressed and non-depressed groups. Depressed individuals were more like to report 
hypertension (χ
2
 = 8.15, df = 1, p = 0.0043) than non-depressed participants. There were no other 
group differences. Of note, higher WML volumes were shown to be significantly related to lower 
MMSE scores (β = −0.13, SE = 0.05, t = −2.46, p = 0.019). 
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Table 1. Participant characteristics: Sociodemographics, hypertension, lab values, and 
white matter lesions (WMLs) 
a
. 
 Total (n = 42) Depressed (n = 29) Non-depressed (n = 13) p value 
b
 
Age in years 68.4 (6.7) 68.3 (6.5) 68.8 (7.5) 0.8 
Sex (female) 19 (45%) 15 (52%) 4 (31%) 0.2 
Race (White) 39 (93%) 26 (90%) 13 (100%) 0.1 
Education in years 15.8 (1.6) 15.8 (1.7) 16.0 (1.5) 0.7 
Hypertension (yes) c 9 (26%) 9 (38%) 0 (0%) 0.004 
Mini-Mental State 
Examination (total score) 
28.7 (1.3) 28.8 (1.1) 28.5 (1.7) 0.5 
Serum ionized calcium (mg/dL) 5.1 (0.2) 5.1 (0.2) 5.1 (0.2) 0.5 
25-hydroxy-vitamin D (ng/mL) 34.5 (12.9) 35.2 (14.7) 32.9 (7.8) 0.6 
Phosphorus (mg/dL) 3.5 (0.5) 3.5 (0.4) 3.5 (0.6) 0.7 
Parathyroid hormone (pg/mL) 31.5 (14.2) 31.8 (13.4) 30.8 (17.7) 0.9 
WML volume (mL) 5.4 (3.6) 5.4 (3.3) 5.3 (4.2) 0.9 
a mean (SD) or # (%). b p value for difference between groups (chi-squared test used to compare proportions; t-test used 
to compare means). c N = 35. 
3.2. Serum Ionized Calcium (Serum Cai) and White Matter Lesion (WML) Volume 
3.2.1. Main Model 
To examine the effect of serum Cai on WML volume, a simple regression model was run. This 
model showed a trend for a positive relationship between serum Cai and WML volume (β = 4.30,  
SE = 2.40, t = 1.79, p = 0.080; see Figure 2). To examine the effect of serum Cai on WML volume 
while controlling for potential confounders, a multivariable linear regression model was run which 
included covariates. Given the small sample, only age and group (depression vs. comparison) were 
included as covariates. This multivariable model also showed a trend for a positive relationship 
between serum Cai and WML volume (β = 4.34, SE = 2.27, t = 1.91, p = 0.063). 
Figure 2. A positive relationship between serum ionized calcium (Cai) and white matter 
lesions (WMLs) (N = 42; trend in multivariable model, p = 0.06). 
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3.2.2. Secondary Analyses 
Role of Depression. As shown in Table 1, there were no significant differences between depressed 
and comparison participants on either serum Cai or WMLs. However, given that depression has been 
shown in prior studies to be related to both of these measures, separate models for depressed and  
non-depressed groups were examined (see Figure 3). Depressed participants showed a significant 
positive relationship between higher serum Cai and greater WML volume, after controlling for age  
(β = 6.41, SE = 2.53, t = 2.53, p = 0.018), while there was no significant association found in  
non-depressed comparison participants (β = −4.04, SE = 3.45, t = −1.17, p = 0.27). 
Figures 3. Bivariate relationships between serum ionized calcium (Cai) and white matter 
lesions (WMLs) in depressed group, (a) significant in multivariable model,  
p = 0.02) and non-depressed comparison group; (b) not significant in multivariable model, 





Male-Female Differences. There were no significant differences between men and women on either 
serum Cai or WMLs. However, separate models for men and women, controlling for age and group 
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(depression vs. comparison), examined the potential for sex differences, and showed a significant 
positive relationship between higher serum Cai and greater WML volume in men (β = 7.49, SE = 3.42, 
t = 2.19, p = 0.041), while there was no significant association found in women (β = 1.85, SE = 3.25,  
t = 0.57, p = 0.58). 
4. Discussion 
This pilot study showed a trend for a positive relationship between greater serum Cai and WMLs, 
after controlling for age, in older adults who participated in a study of late-life depression. In 
subsample analyses, there was a significant positive relationship between serum Cai and WMLs in 
depressed participants, while there was no significant relationship in non-depressed participants. 
Similarly, men exhibited a significant serum Cai-WML relationship, while women did not. Although 
preliminary, these findings suggest that serum Cai may be associated WMLs in older adults, and this 
relationship may differ by sex and in those with depression. Further studies are needed to replicate 
these pilot findings. 
A positive relationship between serum Cai and WMLs is consistent with prior work that has 
identified linkages between WMLs and both dietary calcium and arterial calcification [22–24,40], as 
well as the detrimental effects of elevated serum calcium levels upon arterial calcification [19–21]. 
Our prior study of older adults showed that greater calcium intakes were associated with higher 
volumes of brain lesions, indicating calcium’s potential as an contributing factor [40], but ionic 
calcium measurements were not available at that time. Since WMLs result primarily from ischemia, 
this calcium-lesion finding is consistent with recent studies, including one done with the Heidelberg 
cohort (N = 23,980), showing that greater calcium intakes, especially those from calcium-containing 
dietary supplements, may elevate one’s risk of cardiovascular outcomes [15,17,41–44]. Supplemental 
calcium may increase the risk of WMLs because of its bolus-like effects upon serum calcium 
concentrations [25,26]. Furthermore, elevated serum calcium, even within the normal range, has been 
associated with arterial calcification [19,21,45]. Calcification of vascular smooth muscle occurs with 
aging, renal disease, diabetes, and atherosclerosis, and has been associated cross-sectionally and 
longitudinally with WMLs [23,46–51]. Initially viewed as simply an indicator of atherosclerotic 
burden, evidence now suggests that calcification of coronary and carotid arteries are independently 
associated with WMLs [23,24,47–50,52]. Two longitudinal cohorts (Zoetermeer and Rotterdam) found 
that midlife aortic calcification predicted WMLs in later adulthood [22]. In addition to effects upon 
arterial calcification, serum calcium may have direct influence on brain health, as shown by calcium’s 
effects on neurotransmitter turnover and neurotoxic mechanisms [53–55]. Thus, serum calcium may be 
an important mediator or contributor to WMLs via either arterial calcification or another mechanism. 
The finding of a significant Cai-WML relationship in depressed participants, while not present in 
the non-depressed subsample, may be an anomaly reflecting the variability in this small sample, or 
alternatively may indicate that depression, a disorder characterized by calcium dysregulation, has an 
important influence on serum calcium and brain relationships. The notion that depression may be a 
moderator of the calcium-WML relationship is not new. In the Rotterdam Study both coronary and 
aortic calcification were strongly associated with depressive disorders (odds ratio = 3.89) [56].  
In addition, a small study of elderly depressives and comparison subjects found that carotid 
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atherosclerosis was highly correlated (r = 0.55) with WMLs but only in those with depression [57], 
suggesting that depression is a key moderator. In addition to depression, other disorders of calcium 
metabolism, including hypertension and renal disease, may be important to a calcium-WML relationship. 
In the current study, it is possible that the apparent influence of depression was due in part to 
hypertension, as these two clinical entities overlapped in this sample (as found in other studies). 
The sex difference observed in the Cai-WML relationship, which was significant in men but not 
women, may relate to sex differences in serum calcium during the lifespan [14] and the effects of 
menopause in women [58], or it may result from differences in underlying cardiovascular disease. 
However, as with other findings for this study, sample size is a major limitation. An analysis of 
variance examined the concurrent influence of sex and depression (with interactions) and found neither 
to be significant. It would be premature to speculate further on the implications of the pilot findings 
until they are replicated with a larger sample. 
This study has strengths which include the use of an automated method for quantifying WML 
volumes from MRI [38]; this method provides substantial advantages over technician-influenced  
semi-automated quantitative methods as well as over qualitative rating scales for WMLs, which often 
have poor reliability. In addition, this study examined serum ionized calcium (serum Ca i) rather than 
total calcium. Serum Cai is a superior measure of true calcium status because it is the physiologically 
active component of blood calcium, it is tightly regulated by calcium binding hormones, and it is not 
influenced by protein content of serum. 
Limitations of this pilot study include its cross-sectional nature, which precludes the establishment 
of a directional relationship between serum Cai and WMLs. The small sample size is also a concern, 
limiting both power and our ability to control for potential confounders, including hypertension and 
medication use, as multiple variables could not be included in the models. Generalizability to older 
population groups is limited because the study sample was drawn from a clinical psychiatric study of 
subjects age 60 and over. 
5. Conclusions 
This pilot study showed that higher levels of serum ionized calcium (serum Cai) may be positively 
associated with brain white matter lesions (WMLs) in older adults, particularly among men and in 
those with depression. These preliminary findings need to be replicated in larger samples. No change 
in calcium recommendations is warranted at the present time, at least none based upon this pilot, cross 
sectional study. These preliminary results may indicate that WMLs are another adverse outcome 
associated with elevated serum calcium levels, and point to the potential importance of screening for 
serum ionic calcium in the older adult population. 
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